Copenhagen Medical A/S Revenue and Competitors

København , Denmark

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Copenhagen Medical A/S's estimated annual revenue is currently $48.2M per year.(i)
  • Copenhagen Medical A/S's estimated revenue per employee is $251,000

Employee Data

  • Copenhagen Medical A/S has 192 Employees.(i)
  • Copenhagen Medical A/S grew their employee count by -35% last year.

Copenhagen Medical A/S's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$30.6M12251%N/AN/A
#2
$10.3M415%N/AN/A
#3
$38.4M153-4%N/AN/A
#4
$101.7M40511%N/AN/A
#5
$10M40-7%N/AN/A
#6
$11M447%N/AN/A
#7
$48.2M192-35%N/AN/A
Add Company

What Is Copenhagen Medical A/S?

Copenhagen Medical A/S blev skabt, da coronapandemien ramte Danmark. Her drev vi en række kviktestcentre som en del af Region Hovedstadens coronaberedskab. Denne opgave har givet os værdifuld erfaring med at levere en sundhedsydelse af høj kvalitet. Det fortsætter vi med. Vores mission er at højne danskernes sundhed med fokus på forebyggelse og give større indblik i muligheden for at påvirke eget helbred. Hvor og hvornår, det passer den enkelte bedst. For at sikre fremtidens høje niveau indenfor sundhedsydelser er der behov for øget samarbejde mellem offentlige og private aktører. Vores ydelser tilpasses fremtidens behov for tilgængelighed og fleksibilitet igennem øget digitalisering og individualisering. Læs mere om vores produkter til erhverv på: https://www.cphmed.com/b2b-home/

keywords:N/A

N/A

Total Funding

192

Number of Employees

$48.2M

Revenue (est)

-35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Copenhagen Medical A/S News

2022-04-20 - Battered Biotech Firm CytRx Hires New CEO, Retools

... serial entrepreneur and medical venture capitalist Stephen Snowdy ... licensed out to Copenhagen, Denmark-based Orphazyme A/S in 2011;...

2022-04-17 - FIRST PATIENT WITH BASAL CELL CARCINOMA TREATED ...

HOERSHOLM, Denmark, April 19, 2022 /PRNewswire/ -- TOOsonix A/S, ... "After initial medical CE-marking of the system in June 2020,...

2022-03-30 - BioPorto A/S announces completion of rights issue; capital ...

The 66,938,601 new shares will be admitted to trading and official listing on Nasdaq Copenhagen A/S under the Company's permanent ISIN-code...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.8M193-3%N/A
#2
$27.6M209-11%N/A
#3
$50.8M22033%N/A
#4
$50.8M22033%N/A
#5
N/A2330%N/A